IMR researchers find limited clinical evidence for hemp to treat multiple sclerosis, epilepsy, chronic pain, cancer, inflammation, or constipation, or to promote sleep, and skin and brain health.
Sativex, registered in Malaysia in 2014, is the only NPRA-approved treatment with marijuana components, but the mouth spray for MS symptoms was pulled from market in 2017 on commercial grounds.
Khairy Jamaluddin says cannabis-containing products should be registered with the Drug Control Authority (DCA) as prescribed by the Control of Drugs and Cosmetics Regulation 1984 under the Sale of Drugs Act.